Early Alzheimer’s Disease Self-Scheduler

To qualify for this study, participants must: 

• Be 50-90 years old
• Have a complaint of memory loss and/or a diagnosis of Mild Cognitive Impairment (MCI) due to Alzheimer’s Disease or Mild Alzheimer’s Disease
• Be on a stable dose for at least 4 weeks if receiving approved symptomatic Alzheimer’s Disease treatment 
• Not have had a Transient Ischemic Attack (TIA), stroke, or seizure within 12 months
• Must agree to use effective birth control if you are a woman of childbearing potential or a man whose partner is of childbearing potential
• Additional criteria will apply

PLEASE NOTE: Please confirm your eligibility before your appointment by calling +1 321-305-5015

If you do not see an available appointment, please call +1 321-305-5015 for availability. 

Transportation may be available. Call +1 321-305-5015.  Compensation may be available for time and travel.

By signing up you agree to receive text messages and emails about this and similar studies near you. You can unsubscribe at any time. Text messages and data rates may apply.